Leadership: Randy Teel, Ph.D. Vice President, Corporate Development
Dr. Teel is Vice President, Corporate Development, and is responsible for our corporate strategy, investor relations, and commercial development functions.
Previously, Dr. Teel was VP and Head of Strategy at Alexion Pharmaceuticals, where he was responsible for long-range planning, partnering with the R&D and Commercial organizations as they developed inline and lifecycle management strategies. Dr. Teel also led enterprise risk management and numerous strategic initiatives across the company.
Prior to Alexion, Dr. Teel was an Associate Partner at McKinsey & Company, where he advised biopharmaceutical clients on issues in commercial, medical, and development. He also served numerous other clients in the healthcare industry, including device manufacturers, insurers, and pharmaceutical distributors.
Dr. Teel is president of the board of Integrated Refugee & Immigrant Services (IRIS) and is on the board at Neighborhood Music School, both of which are not-for-profit organizations in New Haven, CT.
Dr. Teel received a Ph.D (Immunobiology) from Yale University and a B.S. (Biology) from Gonzaga University.